Business Context and Reporting Period
My Size, Inc. (MYSZ), a Delaware corporation headquartered in Israel, filed this Form 8-K on November 3, 2023. The filing addresses a regulatory notification regarding the company's continued listing status on the Nasdaq Capital Market.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on compliance with listing standards.
Material Changes
The primary material event is the receipt of a Notification Letter from Nasdaq Listing Qualifications on November 3, 2023. The company is not in compliance with Nasdaq Listing Rule 5550(a)(2) regarding the minimum bid price requirement of $1.00 per share. This deficiency persisted for 30 consecutive business days prior to the notification date.
Outlook, Risks, and Management Commentary
- Compliance Timeline: The company has 180 calendar days, until May 1, 2024, to regain compliance.
- Compliance Criteria: To cure the deficiency, the common stock must maintain a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days.
- Delisting Risk: If compliance is not achieved by May 1, 2024, the company may be eligible for an additional 180-day period if it meets other listing standards (excluding bid price). Failure to qualify for or succeed in a second period will result in a delisting determination, subject to appeal.
- Management Action: Management intends to monitor the stock price and may consider implementing a reverse stock split to regain compliance.
- Immediate Impact: The notification has no immediate effect on the listing or trading of the company's common stock.
Investor Verification Checklist
- Verify the current closing bid price of MYSZ stock relative to the $1.00 threshold.
- Monitor for any future announcements regarding a reverse stock split or other capital structure changes.
- Track the company's progress toward the May 1, 2024, compliance deadline.
- Review subsequent filings for updates on the company's financial health, as this 8-K does not provide financial metrics.